Global Viral-Vectored Vaccines Market Professional Survey Report Forecast 2017-2021

March 2017 | 130 pages | ID: G0AD434F2F8EN
S&P Consulting

Abstracts

This report studies Viral-Vectored Vaccines in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)

• Indian Immunologicals Ltd (India)

Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
By types, the market can be split into

• Type 1
• Type 2
• Type 3

By Application, the market can be split into

• Application 1
• Application 2
• Application 3

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

1 INDUSTRY OVERVIEW OF VIRAL-VECTORED VACCINES

1.1 Definition and Specifications of Viral-Vectored Vaccines
  1.1.1 Definition of Viral-Vectored Vaccines
  1.1.2 Specifications of Viral-Vectored Vaccines
1.2 Classification of Viral-Vectored Vaccines
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Viral-Vectored Vaccines
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF VIRAL-VECTORED VACCINES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Viral-Vectored Vaccines
2.3 Manufacturing Process Analysis of Viral-Vectored Vaccines
2.4 Industry Chain Structure of Viral-Vectored Vaccines

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF VIRAL-VECTORED VACCINES

3.1 Capacity and Commercial Production Date of Global Viral-Vectored Vaccines Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Viral-Vectored Vaccines Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Viral-Vectored Vaccines Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Viral-Vectored Vaccines Major Manufacturers in 2016

4 GLOBAL VIRAL-VECTORED VACCINES OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Viral-Vectored Vaccines Capacity and Growth Rate Analysis
  4.2.2 2016 Viral-Vectored Vaccines Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Viral-Vectored Vaccines Sales and Growth Rate Analysis
  4.3.2 2016 Viral-Vectored Vaccines Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Viral-Vectored Vaccines Sales Price
  4.4.2 2016 Viral-Vectored Vaccines Sales Price Analysis (Company Segment)

5 VIRAL-VECTORED VACCINES REGIONAL MARKET ANALYSIS

5.1 North America Viral-Vectored Vaccines Market Analysis
  5.1.1 North America Viral-Vectored Vaccines Market Overview
  5.1.2 North America 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.1.4 North America 2016 Viral-Vectored Vaccines Market Share Analysis
5.2 China Viral-Vectored Vaccines Market Analysis
  5.2.1 China Viral-Vectored Vaccines Market Overview
  5.2.2 China 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.2.4 China 2016 Viral-Vectored Vaccines Market Share Analysis
5.3 Europe Viral-Vectored Vaccines Market Analysis
  5.3.1 Europe Viral-Vectored Vaccines Market Overview
  5.3.2 Europe 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.3.4 Europe 2016 Viral-Vectored Vaccines Market Share Analysis
5.4 Southeast Asia Viral-Vectored Vaccines Market Analysis
  5.4.1 Southeast Asia Viral-Vectored Vaccines Market Overview
  5.4.2 Southeast Asia 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.4.4 Southeast Asia 2016 Viral-Vectored Vaccines Market Share Analysis
5.5 Japan Viral-Vectored Vaccines Market Analysis
  5.5.1 Japan Viral-Vectored Vaccines Market Overview
  5.5.2 Japan 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.5.4 Japan 2016 Viral-Vectored Vaccines Market Share Analysis
5.6 India Viral-Vectored Vaccines Market Analysis
  5.6.1 India Viral-Vectored Vaccines Market Overview
  5.6.2 India 2012-2017 Viral-Vectored Vaccines Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Viral-Vectored Vaccines Sales Price Analysis
  5.6.4 India 2016 Viral-Vectored Vaccines Market Share Analysis

6 GLOBAL 2012-2017 VIRAL-VECTORED VACCINES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Viral-Vectored Vaccines Sales by Type
6.2 Different Types of Viral-Vectored Vaccines Product Interview Price Analysis
6.3 Different Types of Viral-Vectored Vaccines Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Viral-Vectored Vaccines Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Viral-Vectored Vaccines Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Viral-Vectored Vaccines Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Viral-Vectored Vaccines Growth Driving Factor Analysis
  6.3.5 Other of Viral-Vectored Vaccines Growth Driving Factor Analysis

7 GLOBAL 2012-2017 VIRAL-VECTORED VACCINES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Viral-Vectored Vaccines Consumption by Application
7.2 Different Application of Viral-Vectored Vaccines Product Interview Price Analysis
7.3 Different Application of Viral-Vectored Vaccines Product Driving Factors Analysis
  7.3.1 Office Use of Viral-Vectored Vaccines Growth Driving Factor Analysis
  7.3.2 Personal Use of Viral-Vectored Vaccines Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF VIRAL-VECTORED VACCINES

8.1 Bayer HealthCare AG (Germany)
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Biogenesis-Bago (Argentina)
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Boehringer Ingelheim GmbH (Germany)
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Ceva Sante Animale (France)
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Heska Corporation (US)
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Indian Immunologicals Ltd (India)
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Lohmann Animal Health (US)
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Merck Animal Health (US)
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Merial Ltd. (US)
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

9 DEVELOPMENT TREND OF ANALYSIS OF VIRAL-VECTORED VACCINES MARKET

9.1 Global Viral-Vectored Vaccines Market Trend Analysis
  9.1.1 Global 2017-2021 Viral-Vectored Vaccines Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2021 Viral-Vectored Vaccines Sales Price Forecast
9.2 Viral-Vectored Vaccines Regional Market Trend
  9.2.1 North America 2017-2021 Viral-Vectored Vaccines Consumption Forecast
  9.2.2 China 2017-2021 Viral-Vectored Vaccines Consumption Forecast
  9.2.3 Europe 2017-2021 Viral-Vectored Vaccines Consumption Forecast
  9.2.4 Southeast Asia 2017-2021 Viral-Vectored Vaccines Consumption Forecast
  9.2.5 Japan 2017-2021 Viral-Vectored Vaccines Consumption Forecast
  9.2.6 India 2017-2021 Viral-Vectored Vaccines Consumption Forecast
9.3 Viral-Vectored Vaccines Market Trend (Product Type)
9.4 Viral-Vectored Vaccines Market Trend (Application)

10 VIRAL-VECTORED VACCINES MARKETING TYPE ANALYSIS

10.1 Viral-Vectored Vaccines Regional Marketing Type Analysis
10.2 Viral-Vectored Vaccines International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Viral-Vectored Vaccines by Regions
10.4 Viral-Vectored Vaccines Supply Chain Analysis

11 CONSUMERS ANALYSIS OF VIRAL-VECTORED VACCINES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…

12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Table Product Specifications of Viral-Vectored Vaccines
Table Classification of Viral-Vectored Vaccines
Figure Global Production Market Share of Viral-Vectored Vaccines by Type in 2016
Table Applications of Viral-Vectored Vaccines
Figure Global Consumption Volume Market Share of Viral-Vectored Vaccines by Application in 2016
Figure Market Share of Viral-Vectored Vaccines by Regions
Figure North America Viral-Vectored Vaccines Market Size (2011-2021)
Figure China Viral-Vectored Vaccines Market Size (2011-2021)
Figure Europe Viral-Vectored Vaccines Market Size (2011-2021)
Figure Southeast Asia Viral-Vectored Vaccines Market Size (2011-2021)
Figure Japan Viral-Vectored Vaccines Market Size (2011-2021)
Figure India Viral-Vectored Vaccines Market Size (2011-2021)
Table Viral-Vectored Vaccines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Viral-Vectored Vaccines in 2016
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Industry Chain Structure of Viral-Vectored Vaccines
Table Capacity and Commercial Production Date of Global Viral-Vectored Vaccines Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Viral-Vectored Vaccines Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Viral-Vectored Vaccines Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Viral-Vectored Vaccines Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Viral-Vectored Vaccines 2012-2017
Figure Global 2012-2017 Viral-Vectored Vaccines Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Viral-Vectored Vaccines Market Size (Value) and Growth Rate
Table 2012-2017 Global Viral-Vectored Vaccines Capacity and Growth Rate
Table 2016 Global Viral-Vectored Vaccines Capacity List (Company Segment)
Table 2012-2017 Global Viral-Vectored Vaccines Sales and Growth Rate
Table 2016 Global Viral-Vectored Vaccines Sales List (Company Segment)
Table 2012-2017 Global Viral-Vectored Vaccines Sales Price
Table 2016 Global Viral-Vectored Vaccines Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure North America 2012-2017 Viral-Vectored Vaccines Sales Price
Figure North America 2016 Viral-Vectored Vaccines Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure China 2012-2017 Viral-Vectored Vaccines Sales Price
Figure China 2016 Viral-Vectored Vaccines Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure Europe 2012-2017 Viral-Vectored Vaccines Sales Price
Figure Europe 2016 Viral-Vectored Vaccines Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure Southeast Asia 2012-2017 Viral-Vectored Vaccines Sales Price
Figure Southeast Asia 2016 Viral-Vectored Vaccines Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure Japan 2012-2017 Viral-Vectored Vaccines Sales Price
Figure Japan 2016 Viral-Vectored Vaccines Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Viral-Vectored Vaccines 2012-2017
Figure India 2012-2017 Viral-Vectored Vaccines Sales Price
Figure India 2016 Viral-Vectored Vaccines Sales Market Share
Table Global 2012-2017 Viral-Vectored Vaccines Sales by Type
Table Different Types Viral-Vectored Vaccines Product Interview Price
Table Global 2012-2017 Viral-Vectored Vaccines Sales by Application
Table Different Application Viral-Vectored Vaccines Product Interview Price
Table Bayer HealthCare AG (Germany) Basic Information List
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Biogenesis-Bago (Argentina) Basic Information List
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information List
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Ceva Sante Animale (France) Basic Information List
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ceva Sante Animale (France) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Heska Corporation (US) Basic Information List
Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Heska Corporation (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Indian Immunologicals Ltd (India) Basic Information List
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Lohmann Animal Health (US) Basic Information List
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lohmann Animal Health (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Merck Animal Health (US) Basic Information List
Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Animal Health (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Table Merial Ltd. (US) Basic Information List
Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merial Ltd. (US) Viral-Vectored Vaccines Global Market Share (2012-2017)
Figure Global 2017-2021 Viral-Vectored Vaccines Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Viral-Vectored Vaccines Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Viral-Vectored Vaccines Sales Price Forecast
Figure North America 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Viral-Vectored Vaccines Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Viral-Vectored Vaccines by Types 2017-2021
Table Global Consumption Volume of Viral-Vectored Vaccines by Applications 2017-2021
Table Traders or Distributors with Contact Information of Viral-Vectored Vaccines by Regions